Search

everythinglearnresearchcommunity

for

Search:↓

Fractional laser treatment helped hair regrowth in patients with alopecia areata.

Most vitiligo patients in Makkah are young women, often with family history and thyroid issues.

The document concludes that early diagnosis and treatment are key for pediatric hair loss disorders, and addressing the emotional effects on children is important.

Narrowband UVB phototherapy alone is not very effective for treating alopecia areata.

The book details skin conditions in older adults, their link to mental health, cancer treatment importance, hair loss remedies, and managing autoimmune and itchy skin.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Latanoprost therapy potentially caused a woman's white hair to darken again.

A combination of oral cyclosporin and PUVA treatment worked well for a severe skin condition called generalized pustular psoriasis.

Men with both baldness and scalp psoriasis often don't have psoriasis on bald spots.

Systemic corticosteroids can help treat rapidly spreading vitiligo but require more research for safer use.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Certain skin drugs and topical agents, including some natural extracts and fragrances, can cause allergic reactions. Some hair dyes and extensions, as well as minoxidil, a hair growth treatment, can also cause allergies. Botulinum toxin A can effectively reduce sweat but may have temporary side effects.

The 308-nm Excimer laser is effective and safe for treating patchy alopecia areata in children.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Methotrexate with steroids is slightly more effective than azathioprine with steroids for treating severe alopecia areata.

Current treatments for alopecia show no significant long-term benefits.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Non-invasive methods show promise for diagnosing skin diseases like psoriasis and lupus but need more research for regular use.

The study found that the most common repigmentation pattern in children with vitiligo is a combination of patterns, with a new medium spotted pattern identified.

Treatments for autoimmune hair loss have limited success and often relapse, and emotional support is crucial for those affected.

New skin treatments in 1987-1988 showed effectiveness for various conditions, but some had side effects or risks.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Patient-derived melanocytes can potentially treat vitiligo by restoring skin pigmentation.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

The document concludes that early diagnosis and a comprehensive treatment plan are crucial for managing hair loss in children, with a focus on both medical and psychological support.

The document describes various skin conditions, their features, and treatments but lacks detailed study size information.

Dermatologists' treatment of alopecia areata is inconsistent, especially for children and advanced stages.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.